Insider Transactions in Q2 2022 at Relay Therapeutics, Inc. (RLAY)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2022
|
Sanjiv Patel President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
814
+0.32%
|
$11,396
$14.24 P/Share
|
|
Jun 27
2022
|
Brian Adams Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
300
-0.47%
|
$6,000
$20.31 P/Share
|
|
Jun 27
2022
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
300
-0.56%
|
$6,000
$20.31 P/Share
|
|
Jun 27
2022
|
Andy Porter Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
265
-0.57%
|
$5,300
$20.31 P/Share
|
|
Jun 27
2022
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
999
-1.08%
|
$19,980
$20.31 P/Share
|
|
Jun 24
2022
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
8,000
-7.96%
|
$160,000
$20.0 P/Share
|
|
Jun 24
2022
|
Donald A Bergstrom President, R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+7.37%
|
$32,000
$4.12 P/Share
|
|
May 02
2022
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
13,000
-12.32%
|
$312,000
$24.62 P/Share
|
|
May 02
2022
|
Donald A Bergstrom President, R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
13,000
+10.97%
|
$52,000
$4.12 P/Share
|
|
Apr 28
2022
|
Brian Adams Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
708
-1.1%
|
$17,700
$25.57 P/Share
|
|
Apr 28
2022
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
725
-1.34%
|
$18,125
$25.57 P/Share
|
|
Apr 28
2022
|
Andy Porter Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
435
-0.93%
|
$10,875
$25.57 P/Share
|
|
Apr 28
2022
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
1,811
-1.92%
|
$45,275
$25.57 P/Share
|
|
Apr 14
2022
|
Sanjiv Patel President and CEO |
SELL
Open market or private sale
|
Direct |
28,000
-5.23%
|
$840,000
$30.51 P/Share
|
|
Apr 14
2022
|
Sanjiv Patel President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
28,000
+4.97%
|
$112,000
$4.58 P/Share
|
|
Apr 13
2022
|
Sanjiv Patel President and CEO |
SELL
Open market or private sale
|
Direct |
28,000
-5.23%
|
$868,000
$31.95 P/Share
|
|
Apr 13
2022
|
Sanjiv Patel President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
28,000
+4.97%
|
$112,000
$4.58 P/Share
|
|
Apr 12
2022
|
Sanjiv Patel President and CEO |
SELL
Open market or private sale
|
Direct |
28,000
-9.94%
|
$868,000
$31.8 P/Share
|
|
Apr 12
2022
|
Sanjiv Patel President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
28,000
+9.04%
|
$112,000
$4.12 P/Share
|
|
Apr 01
2022
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
18,000
-16.03%
|
$540,000
$30.32 P/Share
|
|
Apr 01
2022
|
Donald A Bergstrom President, R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
18,000
+13.81%
|
$72,000
$4.12 P/Share
|